# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-004937
Filing Date
2017-05-11
Accepted
2017-05-11 16:06:26
Documents
81
Period of Report
2017-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0317_immucellcorp.htm | 10-Q | 606850
2 | CERTIFICATION | f10q0317ex31_immucellcorp.htm | EX-31 | 9612
3 | CERTIFICATION | f10q0317ex32_immucellcorp.htm | EX-32 | 5491
| Complete submission text file | 0001213900-17-004937.txt |  | 4748421

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | iccc-20170331.xml | EX-101.INS | 920439
5 | XBRL SCHEMA FILE | iccc-20170331.xsd | EX-101.SCH | 49214
6 | XBRL CALCULATION FILE | iccc-20170331_cal.xml | EX-101.CAL | 71574
7 | XBRL DEFINITION FILE | iccc-20170331_def.xml | EX-101.DEF | 126866
8 | XBRL LABEL FILE | iccc-20170331_lab.xml | EX-101.LAB | 487468
9 | XBRL PRESENTATION FILE | iccc-20170331_pre.xml | EX-101.PRE | 314527

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 17834292
SIC: 2835 In Vitro & In Vivo Diagnostic Substances